Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$784M |
| 2 |
PepsiCo
PEP
|
+$635M |
| 3 |
UnitedHealth
UNH
|
+$599M |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$376M |
| 5 |
JPMorgan Chase
JPM
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$510M |
| 2 |
HES
Hess
HES
|
+$465M |
| 3 |
Uber
UBER
|
+$413M |
| 4 |
SLB Ltd
SLB
|
+$404M |
| 5 |
PayPal
PYPL
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.64% |
| 2 | Financials | 10.93% |
| 3 | Healthcare | 9.92% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Yum China
YUMC
$16.3B
| $750K | ﹤0.01% |
13,454
-1,871
| -12% | -$105K |
|
727
PNC Financial Services
PNC
$101B
| $735K | ﹤0.01% |
5,988
-1,193
| -17% | -$150K |
|
728
Teleflex
TFX
$6.15B
| $726K | ﹤0.01% |
3,694
-324
| -8% | -$73.5K |
|
729
Northrop Grumman
NOC
$80.2B
| $709K | ﹤0.01% |
1,611
-401
| -20% | -$176K |
|
730
iShares TIPS Bond ETF
TIP
$14.5B
| $696K | ﹤0.01% |
6,711
-2,180
| -25% | -$231K |
|
731
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $695K | ﹤0.01% |
13,352
+3,328
| +33% | +$183K |
|
732
Sutro Biopharma
STRO
$411M
| $682K | ﹤0.01% |
19,652
| – | – |
|
|
HOLX
733
DELISTED
Hologic
HOLX
| $681K | ﹤0.01% |
9,811
-1,335
| -12% | -$101K |
|
734
Wabtec
WAB
$49.7B
| $675K | ﹤0.01% |
6,350
-244
| -4% | -$27.2K |
|
735
Vanguard High Dividend Yield ETF
VYM
$82.6B
| $673K | ﹤0.01% |
6,510
+1,525
| +31% | +$164K |
|
736
iShares MSCI USA Quality Factor ETF
QUAL
$47.9B
| $669K | ﹤0.01% |
5,078
+2,464
| +94% | +$336K |
|
737
Vanguard Morningstar Small-Cap ETF
VB
$82.2B
| $669K | ﹤0.01% |
3,536
+1,349
| +62% | +$269K |
|
738
Cogent Biosciences
COGT
$7.19B
| $669K | ﹤0.01% |
68,569
| – | – |
|
739
Schwab U.S Small- Cap ETF
SCHA
$23B
| $663K | ﹤0.01% |
32,006
+16,234
| +103% | +$356K |
|
|
PNT
740
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $662K | ﹤0.01% |
99,189
| – | – |
|
741
Becton Dickinson
BDX
$48.6B
| $654K | ﹤0.01% |
2,529
+1,053
| +71% | +$284K |
|
|
SFBS
742
ServisFirst Bancshares
SFBS
$4.85B
| $648K | ﹤0.01% |
12,421
-13,412
| -52% | -$710K |
|
743
Zimmer Biomet
ZBH
$18.4B
| $641K | ﹤0.01% |
5,709
-2
| -0% | -$254 |
|
744
Schwab Fundamental US Small Company Index ETF
FNDA
$9.37B
| $636K | ﹤0.01% |
26,230
+16,546
| +171% | +$422K |
|
745
Papa John's
PZZA
$793M
| $626K | ﹤0.01% |
9,171
+2,170
| +31% | +$168K |
|
746
iShares Core S&P Small-Cap ETF
IJR
$112B
| $616K | ﹤0.01% |
6,529
+762
| +13% | +$76.1K |
|
747
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $615K | ﹤0.01% |
12,346
-3,671
| -23% | -$184K |
|
748
Dow Inc
DOW
$21.5B
| $615K | ﹤0.01% |
11,930
+3,136
| +36% | +$168K |
|
749
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $612K | ﹤0.01% |
12,571
-3,857
| -23% | -$192K |
|
750
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.16B
| $610K | ﹤0.01% |
26,000
-391
| -1% | -$9.5K |
|
Similar funds
Ken Fisher's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Fisher held 1,293 positions worth $176B, down 2.5% from $181B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Fisher's Q3 2023 filing shows 130 new, 437 increased, 474 reduced and 125 closed positions. Its largest new stake was Murphy Oil: 991,976 shares worth $45M. The largest sale was ExxonMobil, an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2023 buy was Murphy Oil: 991,976 shares worth $45M.
- Ken Fisher added most to Procter & Gamble in Q3 2023, an estimated $784M increase.
- Ken Fisher's biggest Q3 2023 reduction was ExxonMobil, cutting an estimated $510M.
- Ken Fisher fully exited PDC Energy, Inc. in Q3 2023, selling an estimated $78.7M.
- Ken Fisher's ten largest holdings make up 27% of its $176B portfolio in Q3 2023.
- Ken Fisher opened 130 new positions and closed 125 in Q3 2023.
- Ken Fisher's portfolio value fell 2.5% quarter-over-quarter to $176B.
Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.